Skip to main content


List of recent publications by Dr Moez Dungarwalla, Haematology Specialist.

Cough and a sore throat – more than just swine flu?

A 25-year-old non-smoking warehouse worker presented to the acute medical take with a five-day history of worsening symptoms including anorexia, lethargy, myalgia, swinging fevers and night sweats. He had been seen by his general practitioner at the start of this illness and commenced on oseltamivir to treat presumed H1N1 influenza

High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis

Abstract: In a series of 48 patients with splenic marginal zone lymphoma (SMZL) with circulating villous lymphocytes, we describe the clinical and laboratory features of nine cases that transformed to high-grade B-cell lymphoma. These patients had a significantly greater incidence of …

Prolymphocytic leukaemia of B and T cell subtype: a state of the art paper

Abstract: Prolymphocytic leukaemias of B and T cell subtype are rare diseases. Despite recent advances in immunophenotyping and molecular cytogenetics, leading to a better understanding of the underlying cell biology of the prolymphocytic leukaemias, prognosis for these patients …

Cutaneous Mycobacterium chelonae infection in chronic lymphocytic leukaemia

Abstract: We describe 11 patients with severe refractory autoimmune cytopenias treated with
the anti-CD20 mono- clonal antibody rituximab. Six patients had autoimmune neutropenia
(AIN), two had pure red cell aplasia (PRCA), one had AIN and autoimmune haemolytic …

Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology

Abstract:  A 67 year old man was diagnosed with chronic lympho- cytic leukaemia (CLL) in 1999. He was also known to have hypogammaglobulinaemia and bronchiectasis. He had been previously treated with 12 cycles of chloram- bucil, 2 cycles of fludarabine …

High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy

Abstract: The combination of high dose methylprednisolone and rituximab induces superior overall (93%) and complete (14%) response rates compared to high dose methylprednisolone alone (overall 43%, complete remission 0%) in heavily pre-treated chronic lymphocytic leukemia patients with advanced disease…

Soon to be published:

1. Idelalisib-Rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme.

Journal: British Journal of Haematology

2. “Real World” use of Ixazomib in combination with Lenalidomide and Dexamethasone as ≥3rd line therapy in Relapsed/Refractory Myeloma in the UK: A Multicentre Experience

Journal: British Journal of Haematology

Author of Chapter – “Infective Complications in Acute Myeloid Leukaemia”

Publication in Leukaemia Care Information Booklet for Patients diagnosed with Acute Myeloid Leukaemia

To book a consultation

Get in touch and book your consultation with us today.